KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Deferred Taxes (2016 - 2025)

Globus Medical (GMED) has disclosed Deferred Taxes for 15 consecutive years, with $18.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 154.55% year-over-year to $18.1 million, compared with a TTM value of $18.6 million through Dec 2025, up 114.79%, and an annual FY2025 reading of $18.6 million, up 114.79% over the prior year.
  • Deferred Taxes was $18.1 million for Q4 2025 at Globus Medical, down from $41.8 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $41.8 million in Q3 2025 and bottomed at -$45.1 million in Q1 2024.
  • Average Deferred Taxes over 5 years is -$10.2 million, with a median of -$6.2 million recorded in 2022.
  • The sharpest move saw Deferred Taxes crashed 12170.0% in 2021, then surged 252.15% in 2025.
  • Year by year, Deferred Taxes stood at -$14.5 million in 2021, then soared by 64.04% to -$5.2 million in 2022, then crashed by 126.51% to -$11.8 million in 2023, then plummeted by 181.2% to -$33.2 million in 2024, then soared by 154.55% to $18.1 million in 2025.
  • Business Quant data shows Deferred Taxes for GMED at $18.1 million in Q4 2025, $41.8 million in Q3 2025, and -$41.7 million in Q2 2025.